Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Clin Cancer Res. 2014 Dec 17;21(5):1063–1070. doi: 10.1158/1078-0432.CCR-14-1715

Figure 2. [18F]FFNP uptake in the SSM3 tumors and uteri was specific to PgR.

Figure 2

The unlabeled forms of the PgR-selective ligand R5020 or glucocorticoid receptor (GR)-selective ligand dexamethasone (Dex) were injected into SSM3 tumor-bearing mice immediately before the injection of [18F]FFNP (5 mice per group). The indicated organs were harvested. The in vivo tissue biodistribution of [18F]FFNP was determined in the harvested tissues 1 hr post-FFNP injection. Representative results from 3 independent experiments are shown. * p<0.05, *** p<0.001. ns = not significant.